| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1988) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | K5BC5011K3 |
| Parent Compound: | NICARDIPINE |
Structure
| InChI Key | AIKVCUNQWYTVTO-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C26H30ClN3O6 |
| Molecular Weight | 515.99 |
| AlogP | 3.68 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 111.01 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 35.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 57 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cerebral Hemorrhage | 3 | D002543 | ClinicalTrials |
| Vasospasm, Intracranial | 2 | D020301 | ClinicalTrials |
| Cardiovascular Diseases | 1 | D002318 | ClinicalTrials |
Related Entries
Scaffolds
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 7551 |
| ChEMBL | CHEMBL1200326 |
| EPA CompTox | DTXSID9046992 |
| FDA SRS | K5BC5011K3 |
| KEGG | C07264 |
| PubChem | 41114 |
| SureChEMBL | SCHEMBL41845 |
| ZINC | ZINC84400879 |
CONTENTS